Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 5, 1997, Pages 447-453

  Jiang, Guo Xin ^a   Cheng, Qi ^a   Link, Hans ^a   De Pedro Cuesta, Jesús ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Epidemiology; Guillain barr syndrome; Incidence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEASONAL VARIATION; SEX DIFFERENCE; SWEDEN;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; RETROSPECTIVE STUDIES; SWEDEN;

EID: 0030949048     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.5.447     Document Type: Review

References (29)

1. D'Ambrosio G, De Angelis G, Vizioli R. Epidemiology of Guillain-Barré syndrome in Campania (south Italy). Preliminary results. Acta Neurol 1983;23:245-52.
2. Beghi E, Kurland LT, Mulder DW, Wiederholt WC. Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 1985;42: 1053-7.
3. Larsen JP, Kvåle G, Nyland H. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, western Norway. Acta Neurol Scand 1985;71:43-7.
4. Kaplan JE, Poduska PJ, McIntosh GC, Hopkins RS, Ferguson SW, Schonberger LB. Guillain-Barré syndrome in Larimer County, Colorado: a high-incidence area. Neurology 1985;35:581-4.
5. Radhakrishan K, El-Mangoush MA, Rerryo SE. Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol Scand 1987;75:95-100.
6. Hankey GJ. Guillain-Barré syndrome in Western Australia, 1980-5. Med J Aust 1987;146:130-3.
7. Congia S, Melis M, Carboni MA. Epidemiologic and clinical features of the Guillain-Barré syndrome in Sardinia in the 1961-80 period. Acta Neurol 1989;11:15-20.
8. Jiang G-X, de Pedro-Cuesta J, Fredrikson S. Guillain-Barré syndrome in south-west Stockholm, 1973-91, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995;91:109-17.
9. de Pedro-Cuesta J, Abraira V, Jiang G-X, Solders G, Fredrikson S, Guillain-Barré syndrome in south-west Stockholm, 1973-91, 3. Clinicoepidemiological subgroups. Acta Neurol Scand 1996;93:175-83.
10. Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL. The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 1991;30: 618-21.
11. Jiang G-X, de Pdero-Cuesta J, Cheng Q, Ehrnst A, Link H. Guillain-Barré syndrome in Stockholm County, 1973-91. Eur J Epidamiol 1997;13:25-32.
12. National Institute of Neurologic and Communication Disorders and Stroke Ad Hoc Committee. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978; 3:565-6.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
14. Robins J, Greenland S, Breslow NE. A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986;124:719-23.
15. Wallenstein S. A test for detection of clustering over time. Am J Epidemiol 1980;111:367-71.
16. Naus JI. Approximations for distributions of Scan statistics. Journal of the American Statistical Association 1982;77: 177-83.
17. Armitage P, Berry G. eds. Statistical methods in medical research. 2nd ed, Oxford: Blackwell Sci Publ, 1987: 200-13.
18. Pettersson B, Coleman MP, Ron E, Adami H-O. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 1996;65:13-9.
19. Ohno Y, Aoki K, Aoki N. A test of significance for geographic clusters of disease. Int J Epidemiol 1979;8:273-81.
20. McLean M, Duclos P, Jacob P, Humphreys P. Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-9, using hospital service databases. Epidemiology 1994;5:443-8.
21. Kaplan JE, Schonberger LB, Hurwitz ES, Katona P. Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology 1983;33:633-7.
22. Fagius J, Osterman PO, Sidén Å, Wiholm B-E. Guillain-Barré syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry 1985;48:65-9.
23. HSN - områdesdata 1990 för Stockholms län. Stockholms läns landsting, Regionplane-och trafikkontoret Rapport 1990:2. Stockholm: 1990:1-107.
24. Ropper AH, Wijdicks EFM, Truax BT, eds. Guillain-Barré syndrome. Philadelphia: FA Davis, 1991:27.
25. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40: 1900-2.
26. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China, relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118: 597-605.
27. Visser LH, Van Der Meché FGA, Van Doorn PA, Meulstee J, Jacobs BC, Oomes PG, Kleyweg RP, and Dutch Guillain-Barré Study Group. Guillain-Barré syndrome without sensory loss (acute motor neuropathy), a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-7.
28. Rees JH, Soudain SE, Gregson NA, Hughes RCA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
29. Walder M. Epidemiology of Campylobacter enteritis. Scand J Infect Dis 1982;14:27-33.